---
figid: PMC6627250__PDIA-36-84590-g001
figtitle: Neoplastic transformation of melanocyte
organisms:
- Homo sapiens
- Human alphaherpesvirus 1
- clinical samples
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC6627250
filename: PDIA-36-84590-g001.jpg
figlink: /pmc/articles/PMC6627250/figure/f0001/
number: F1
caption: Neoplastic transformation of melanocyte. Upon mutation in BRAF or NRAS gene,
  melanocyte acquires the ability to sustained proliferation. Subsequent mutation
  in the promotor of TERT enables the cell to avoid senescence while inhibition of
  RB and p53 pathways suppresses cell cycle control and apoptosis. At this point melanocyte
  turns into melanoma cell. Further activation of PI3K/AKT pathway and involvement
  of other tumour-related proteins (e.g. MITF, WNT, STAT3, NOTCH) regulates such processes
  as invasive growth, induction of angiogenesis and immunosuppression. Finally, all
  the aforementioned molecular changes lead to development of aggressive, metastatic
  melanoma cell
papertitle: 'Molecular background of skin melanoma development and progression: therapeutic
  implications.'
reftext: Magdalena Olbryt. Postepy Dermatol Alergol. 2019 Apr;36(2):129-138.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8758695
figid_alias: PMC6627250__F1
figtype: Figure
redirect_from: /figures/PMC6627250__F1
ndex: 030ac287-df17-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6627250__PDIA-36-84590-g001.html
  '@type': Dataset
  description: Neoplastic transformation of melanocyte. Upon mutation in BRAF or NRAS
    gene, melanocyte acquires the ability to sustained proliferation. Subsequent mutation
    in the promotor of TERT enables the cell to avoid senescence while inhibition
    of RB and p53 pathways suppresses cell cycle control and apoptosis. At this point
    melanocyte turns into melanoma cell. Further activation of PI3K/AKT pathway and
    involvement of other tumour-related proteins (e.g. MITF, WNT, STAT3, NOTCH) regulates
    such processes as invasive growth, induction of angiogenesis and immunosuppression.
    Finally, all the aforementioned molecular changes lead to development of aggressive,
    metastatic melanoma cell
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CDKN2A
  - BRAF
  - PTEN
  - TERT
  - NRAS
  - KIT
  - TP53
  - TP63
  - TP73
  - SLC25A4
  - SLC25A6
  - ETM2
  - CDH2
  - POLI
  - MITF
  - FBXW7
  - NOTO
  - STAT3
  - SPARC
  - MMP1
  - MMP2
  - MMP3
  - MMP7
  - MMP8
  - MMP9
  - MMP10
  - MMP11
  - MMP12
  - MMP13
  - MMP14
  - MMP15
  - MMP16
  - MMP17
  - MMP19
  - MMP20
  - MMP21
  - MMP23B
  - MMP24
  - MMP25
  - MMP26
  - MMP27
  - MMP28
  - SPP1
  - MME
  - TAS2R6P
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - BMP6
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - Pten
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - p53
  - betaTub60D
  - hth
  - ant
  - sesB
  - Antp
  - ems
  - CadN
  - shg
  - 'On'
  - PolI
  - gr
  - Mitf
  - ago
  - Mmp1
  - scb
  - bra
  - byn
  - .na.character
  - 'NO'
  - ether
  - Mucosal and acral melanomas
---
